{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:24:39Z","timestamp":1790774679042,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000351","name":"British Lung Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000723","name":"Tenovus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.chest.2019.10.030","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T02:25:15Z","timestamp":1573525515000},"page":"815-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Validation of the COPD Assessment Test (CAT) as an Outcome Measure in Bronchiectasis"],"prefix":"10.1016","volume":"157","author":[{"given":"Simon","family":"Finch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena F.","family":"Laska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Abo-Leyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Fardon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.chest.2019.10.030_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00208-2017","article-title":"Health-related quality of life questionnaires in bronchiectasis: the simplest way to quantify complexity","volume":"49","author":"Olveira","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2019.10.030_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/thoraxjnl-2014-205918","article-title":"Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores","volume":"70","author":"Quittner","year":"2015","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.chest.2019.10.030_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01926-2017","article-title":"Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial","volume":"51","author":"Munoz","year":"2018","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2019.10.030_bib4","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2019.10.030_bib5","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1183\/09031936.00160508","article-title":"Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis","volume":"34","author":"Murray","year":"2009","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2019.10.030_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2019.10.030_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02232-2017","article-title":"ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence","volume":"51","author":"Wong","year":"2018","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2019.10.030_bib8","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01953-2017","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis","volume":"51","author":"Araujo","year":"2018","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2019.10.030_bib9","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01532-2016","article-title":"The development and validation of the Bronchiectasis Health Questionnaire","volume":"49","author":"Spinou","year":"2017","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2019.10.030_bib10","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-018-0631-7","article-title":"\u201cThe missing ingredient\u201d: The patient perspective of health related quality of life in bronchiectasis: a qualitative study","volume":"18","author":"Dudgeon","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"2 Pt 1","key":"10.1016\/j.chest.2019.10.030_bib11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1164\/ajrccm.156.2.9607083","article-title":"Validation of the St. George\u2019s Respiratory Questionnaire in bronchiectasis","volume":"156","author":"Wilson","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.chest.2019.10.030_bib12","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions","volume":"52","author":"Polverino","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2019.10.030_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01312-2017","article-title":"Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future?","volume":"51","author":"Spruit","year":"2018","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2019.10.030_bib14","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.chest.2019.10.030_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(18)30053-5","article-title":"Bronchiectasis: new therapies and new perspectives","author":"Chalmers","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"4","key":"10.1016\/j.chest.2019.10.030_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01655-2017","article-title":"Precision medicine in airway diseases: moving to clinical practice","volume":"50","author":"Agust\u00ed","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2019.10.030_bib17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01269-2018","article-title":"Treatable traits in bronchiectasis","volume":"52","author":"Boaventura","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2019.10.030_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02444-2017","article-title":"RESPIRE: breathing new life into bronchiectasis","volume":"51","author":"Chotirmall","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2019.10.030_bib19","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02053-2017","article-title":"RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"Aksamit","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2019.10.030_bib20","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02052-2017","article-title":"RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"De Soyza","year":"2018","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.chest.2019.10.030_bib21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/thoraxjnl-2014-205587","article-title":"Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial","volume":"69","author":"Bilton","year":"2014","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.chest.2019.10.030_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00412-2018","article-title":"Clinically relevant differences in COPD health status: systematic review and triangulation","volume":"52","author":"Alma","year":"2018","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2019.10.030_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S2213-2600(14)70001-3","article-title":"Minimum clinically important difference for the COPD Assessment Test: a prospective analysis","volume":"2","author":"Kon","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.chest.2019.10.030_bib24","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1183\/09031936.00102509","article-title":"Development and first validation of the COPD Assessment Test","volume":"34","author":"Jones","year":"2009","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2019.10.030_bib25","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1080\/15412555.2018.1540034","article-title":"COPD Assessment Test (CAT) is a valid and simple tool to measure the impact of bronchiectasis on affected patients","volume":"15","author":"Lanza","year":"2018","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.chest.2019.10.030_bib26","first-page":"85","article-title":"Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot\u00a0randomized controlled trial","volume":"19","author":"Chalmers","year":"2019","journal-title":"BMC\u00a0Pulm Med"},{"issue":"6","key":"10.1016\/j.chest.2019.10.030_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01289-2017","article-title":"Standardised classification of the aetiology of bronchiectasis using an objective algorithm","volume":"50","author":"Araujo","year":"2017","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1016\/j.chest.2019.10.030_bib28","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/thoraxjnl-2016-208481","article-title":"Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts","volume":"71","author":"McDonnell","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.chest.2019.10.030_bib29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4137\/CCRPM.S40792","article-title":"The COPD assessment test as a prognostic marker in interstitial lung disease","volume":"10","author":"Someya","year":"2016","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"issue":"6","key":"10.1016\/j.chest.2019.10.030_bib30","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/resp.12084","article-title":"Response of the COPD assessment test to pulmonary rehabilitation in unselected chronic respiratory disease","volume":"18","author":"Kon","year":"2013","journal-title":"Respirology"},{"key":"10.1016\/j.chest.2019.10.030_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12931-015-0167-9","article-title":"Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study","volume":"16","author":"Brill","year":"2015","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.chest.2019.10.030_bib32","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01888-2015","article-title":"Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration","volume":"48","author":"Aliberti","year":"2016","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2019.10.030_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-2600(18)30427-2","article-title":"Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials","volume":"7","author":"Haworth","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.chest.2019.10.030_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1164\/rccm.201809-1651OC","article-title":"Airway bacterial load and inhaled antibiotic response in bronchiectasis","volume":"200","author":"Sibila","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.chest.2019.10.030_bib35","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/thoraxjnl-2014-205587","article-title":"Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial","volume":"69","author":"Bilton","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.chest.2019.10.030_bib36","article-title":"COPD assessment test in bronchiectasis: minimum clinically important difference and psychometric validation: a prospective study","author":"De la Rosa Carrillo","year":"2019","journal-title":"Chest"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219341984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369219341984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T22:58:40Z","timestamp":1762124320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369219341984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0012369219341984"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2019.10.030","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Validation of the COPD Assessment Test (CAT) as an Outcome Measure in Bronchiectasis","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2019.10.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}